Loblaw Companies Limited · TSX:L
Loblaw Companies — Q1 2025 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Mar 22, 2025
Slide 1: Supplementary Slides Q1 2025
SUPPLEMENTARY SLIDES Q1 2025 For the periods ended March 22, 2025 and March 23, 2024 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q1 2025 (millions of Canadian dollars unless otherwise noted) Q1 2025 Q1 2024 % Change (1) Consolidated Revenue $14,135 $13,581 ↑ +4.1% Adjusted EBITDA $1,591 $1,544 ↑ +3.0% Adjusted EBITDA Margin 11.3 % 11.4 % ↓ (10bps) Adjusted Net Earnings Avaliable to Common
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q1 2025 (millions of Canadian dollars unless otherwise noted) Q1 2025 Q1 2024 % Change (1) Total Retail Revenue $13,837 $13,290 ↑ 4.1% Retail Revenue - Food $9,787 $9,409 ↑ 4.0% Retail Revenue - Drug $4,050 $3,881 ↑ 4.4% Pharmacy and Healthcare Services $2,201
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q1 2025 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +2.2% Basket Size(2) ↑ Traffic(2) ≈ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +3.8